Gene silencing drug safe in ALS patients bring on Huntington's

RNAi-based therapies for Huntington's disease: delivery challenges and opportunities

Oligodendrocyte pathology in Huntington's disease: from mechanisms to therapeutics: Trends in Molecular Medicine

Frontiers Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock

Huntingtin suppression restores cognitive function in a mouse model of Huntington's disease

Frontiers Polyglutamine Expansion in Huntingtin and Mechanism of DNA Damage Repair Defects in Huntington's Disease

RNAi-based therapies for Huntington's disease: delivery challenges and opportunities

Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis - The Lancet Neurology

Frontiers Contribution of Neuroepigenetics to Huntington's Disease

Pharmaceuticals, Free Full-Text

IJMS, Free Full-Text

Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic

MORE